U.K. reclassifies liquid paracetamol
This article was originally published in The Tan Sheet
Executive Summary
The Medicines and Healthcare products Regulatory Agency increases the maximum strength of liquid paracetamol, marketed as acetaminophen in the U.S., available for general sale from 2.5 percent to 5 percent for use by adults and children over 12 years of age. Liquid paracetamol preparations previously could only be offered in general sale - the equivalent of OTC in the U.S. - in 2.5 percent solutions and consumers would have to buy 5 percent preparations from a pharmacist, the U.K. agency announces Aug. 21
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.